ANXA1 and allergic contact dermatitis: We described the therapeutic potential of intrathecal and intravenous ANXA1 mimetic peptide Ac2-26 in chronic itching using two mice models of allergic contact dermatitis-induced itch and cholestatic itch in this pre-clinical research.